Item Type | Name |
Concept
|
Cholesterol, HDL
|
Academic Article
|
Age-dependence of the relationship between adiposity and serum low density lipoprotein cholesterol in men.
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
|
Academic Article
|
Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
|
Academic Article
|
Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women.
|
Academic Article
|
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
|
Academic Article
|
Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia.
|
Academic Article
|
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
|
Academic Article
|
Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication.
|
Academic Article
|
Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.
|
Academic Article
|
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet.
|
Academic Article
|
Low-density lipoprotein subclass distribution pattern and adiposity-associated dyslipidemia in postmenopausal women.
|
Academic Article
|
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
|
Academic Article
|
A look to the future: new treatment guidelines and a perspective on statins.
|
Academic Article
|
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
|
Academic Article
|
Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
|
Academic Article
|
High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men.
|
Academic Article
|
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
|
Academic Article
|
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
|
Academic Article
|
Management of hypercholesterolaemia in postmenopausal women.
|
Academic Article
|
Combination therapy for dyslipidemia: safety and regulatory considerations.
|
Academic Article
|
A cross-sectional study of lipids and ApoC levels in Alzheimer's patients with and without cardiovascular disease.
|
Academic Article
|
The safety and immunogenicity of a CETP vaccine in healthy adults.
|
Academic Article
|
Lipid responses in mildly hypertriglyceridemic men and women to consumption of docosahexaenoic acid-enriched eggs.
|
Academic Article
|
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
|
Academic Article
|
Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults.
|
Academic Article
|
Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol.
|
Academic Article
|
Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
|
Academic Article
|
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.
|
Academic Article
|
Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.
|
Academic Article
|
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin.
|
Academic Article
|
High-density lipoprotein metabolism: potential therapeutic targets.
|
Academic Article
|
Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
|
Academic Article
|
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
|
Academic Article
|
Should every patient with diabetes receive a statin?
|
Academic Article
|
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
Academic Article
|
The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.
|
Academic Article
|
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
|
Academic Article
|
Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
|
Academic Article
|
Novel targets that affect high-density lipoprotein metabolism: the next frontier.
|
Academic Article
|
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
|
Academic Article
|
Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease.
|
Academic Article
|
Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction.
|
Academic Article
|
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
|
Academic Article
|
Safety of anacetrapib in patients with or at high risk for coronary heart disease.
|
Academic Article
|
High-density lipoproteins: marker of cardiovascular risk and therapeutic target.
|
Academic Article
|
Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus.
|
Academic Article
|
Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet.
|
Academic Article
|
Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.
|
Academic Article
|
Focus on HDL as a therapeutic target for CAD risk reduction.
|
Academic Article
|
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
|
Academic Article
|
Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu.
|
Academic Article
|
Apolipoprotein measurements: is more widespread use clinically indicated?
|
Academic Article
|
Apolipoprotein A-I therapy promise, challenges, and disappointment.
|
Academic Article
|
A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
|
Academic Article
|
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
|
Academic Article
|
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).
|
Academic Article
|
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
|
Academic Article
|
Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
|
Academic Article
|
Diabetes mellitus in midlife and the risk of dementia three decades later.
|
Academic Article
|
Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
|
Academic Article
|
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
|
Academic Article
|
A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
|
Academic Article
|
Therapies targeting exogenous cholesterol uptake: new insights and controversies.
|
Academic Article
|
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein.
|
Academic Article
|
Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease.
|
Academic Article
|
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
|
Academic Article
|
The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
|
Academic Article
|
Pharmacological approaches to modifying HDL: more basic science to understand HDL metabolism is necessary. Editorial to: "NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells" by Xin Ma et al.
|
Academic Article
|
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib.
|
Academic Article
|
Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
|
Academic Article
|
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
|
Academic Article
|
Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.
|
Academic Article
|
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
|
Academic Article
|
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
|
Academic Article
|
Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
|
Academic Article
|
Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids.
|
Academic Article
|
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
|
Academic Article
|
The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature.
|
Academic Article
|
The Battle of the HDL Subfractions.
|
Academic Article
|
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
|
Academic Article
|
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
|